DMAC vs MDB · $157.4M cap vs rev $2.46B
DiaMedica Therapeutics Inc (DMAC) versus MongoDB (MDB) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
MongoDB (MDB) is a software - infrastructure company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported MDB revenue for 2026-01-31 was $2.46B. Net income was -$71.2M. Revenue was up 22.8% from 2025-01-31 to 2026-01-31. MDB currently screens at market cap $17.16B.
DMAC currently screens at market cap $157.4M. MDB currently screens at market cap $17.16B.
Not investment advice. Open the DMAC and MDB stock pages for the full models.
Not investment advice.